RxDoctor Payments Data

Loralee Romano, APRN

Family · Wadsworth, OHNPI 1336864214

Payments from drug & device makers

$1,274in general payments, 2019–2025

Across 77 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$278
  • Novo Nordisk$219
  • GSK$127
  • Lilly USA, LLC$126
  • E.r. Squibb & Sons, L.L.C.$94
  • AstraZeneca$91
  • plus $340 from 12 others

What the payments were for

  • Food & beverage$1,274100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,274 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$17,322
Medicare patients
92
Services billed
259

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide72$81,004
JardianceEmpagliflozin64$54,708
Trelegy ElliptaFluticasone/Umeclidin/Vilanter67$54,239
FarxigaDapagliflozin Propanediol39$33,849
EliquisApixaban33$32,779
JanuviaSitagliptin Phosphate14$22,955
MounjaroTirzepatide14$20,894
Atorvastatin Calcium337$2,950
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,938
Omeprazole119$1,851
Levothyroxine Sodium191$1,842
Rosuvastatin Calcium153$1,735
SynthroidLevothyroxine Sodium27$1,334
Albuterol Sulfate HfaAlbuterol Sulfate37$974
Venlafaxine Hcl ErVenlafaxine Hcl28$939

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$219$81,00472 claims
Boehringer IngelheimJardiance$85$54,70864 claims
GSKTrelegy Ellipta$127$54,23967 claims
AstraZenecaFarxiga$91$33,84939 claims
PfizerEliquis$44$32,77933 claims
MerckJanuvia$30$22,95514 claims
Lilly USA, LLCMounjaro$126$20,89414 claims
AbbVieSynthroid$278$1,33427 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.

Other family in Wadsworth

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →